Much of the research—so far—about the impact of the Covid-19 pandemic on mental health has been focused on healthcare workers and the general public. However, new studies are taking a deeper look at the mental health impact on individuals with COVID-19. Early findings...
In early 2019, the FDA approved esketamine (marketed as Spravato™) as an additional therapy option for the management of treatment-resistant depression. Like its parent compound, ketamine, Spravato aids in the restoration of synaptic connections in the brain, which is...
Researchers have been exploring how gratitude can improve mental health for years now. They’ve found that it could actually alleviate depression symptoms in some people. Practicing gratefulness has a huge impact on our mindset, and it is not that being happy makes us...
Seasonal Affective Disorder (SAD) is a type of recurrent depression that many people suffer from, and it can look a lot like clinical depression. SAD was first identified by Dr. Normal E. Rosenthal in 1980, and it is estimated that 5% of the population (or one in 20...
The business world has gone virtual, and it looks like this may be the “new normal” for some time to come. A predominantly remote workforce isn’t all bad: the daily rat race is calmer without a bumper-to-bumper commute, and our home is arguable more comfortable than...
Recent Comments